Developpement d’un modèle d’étude de la toxicité du peptide amyloïde Aβ₄₂ chez la levure saccharomyces cerevisiae

Developpement d’un modèle d’étude de la toxicité du peptide amyloïde Aβ₄₂ chez la levure saccharomyces cerevisiae

La Maladie d’Alzheimer (MA) est un des challenges sanitaires les plus importants du XXIème siècle. En effet, elle touche 35,6 millions de personnes en 2010, et en atteindra probablement quatre fois plus en 2050.Cependant, peu d’éléments sont à ce jour connus concernant les mécanismes de toxicité de...

Full description

Bibliographic Details
Main Author:	Angelo, Fabien d'
Other Authors:	Bordeaux 2
Language:	fr
Published:	2011
Subjects:	Levure Amyloïdes Alzheimer Aβ Trafic intracellulaire Toxicité Yeast Amyloids Intracellular trafficking Toxicity
Online Access:	http://www.theses.fr/2011BOR21876/document

Similar Items

Étude de la toxicité du peptide amyloïde beta Aß42 dans la levure Saccharomyces cerevisiae
by: Vignaud, Hélène
Published: (2013)

Amino-Terminal β-Amyloid Antibody Blocks β-Amyloid-Mediated Inhibition of the High-Affinity Choline Transporter CHT
by: Leah K. Cuddy, et al.
Published: (2017-11-01)

Modulation of β-Amyloid Fibril Formation in Alzheimer’s Disease by Microglia and Infection
by: Madeleine R. Brown, et al.
Published: (2020-11-01)

LRP10 (LDL-related protein 10), un nouveau régulateur du trafic et du clivage de la protéine APP (amyloid precursor protein), est réduit dans la maladie d'Alzheimer
by: Brodeur, Julie
Published: (2012)

β-amyloid oligomers in aging and Alzheimer's disease
by: Kathleen R. Zahs, et al.
Published: (2013-07-01)

Induction of amyloid-β deposits from serially transmitted, histologically silent, Aβ seeds issued from human brains
by: Anne-Sophie Hérard, et al.
Published: (2020-11-01)

Deposition of amyloid fibrils promotes cell-surface accumulation of amyloid β precursor protein
by: Lorena Heredia, et al.
Published: (2004-08-01)

Sorting nexin 12 interacts with BACE1 and regulates BACE1-mediated APP processing
by: Zhao Yonghao, et al.
Published: (2012-06-01)

Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivo
by: Raya Al-Shawi, et al.
Published: (2016-01-01)

A novel antagonistic role of natural compound icariin on neurotoxicity of amyloid β peptide
by: Jianhui Liu, et al.
Published: (2015-01-01)

The polarity protein Par3 regulates APP trafficking and processing through the endocytic adaptor protein Numb
by: Miao Sun, et al.
Published: (2016-09-01)

Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
by: Fuyuki Kametani, et al.
Published: (2018-01-01)

A Bifunctional Anti-Amyloid Blocks Oxidative Stress and the Accumulation of Intraneuronal Amyloid-Beta
by: Silvia Hilt, et al.
Published: (2018-08-01)

A Preliminary Study of Cu Exposure Effects upon Alzheimer’s Amyloid Pathology
by: Alexander Pilozzi, et al.
Published: (2020-03-01)

Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
by: Noelia Fandos, et al.
Published: (2017-01-01)

Role of sphingolipids and polyubiquitin chains in intracellular trafficking of the yeast Gap1 permease
by: Lauwers, Elsa
Published: (2007)

Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid β-protein metabolism in mouse models of Alzheimer disease
by: Matthew L. Hemming, et al.
Published: (2007-04-01)

Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia
by: Dietmar Rudolf Thal, et al.
Published: (2019-11-01)

The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets
by: Xue-mei Qi, et al.
Published: (2017-08-01)

Etude de la structure et de la toxicité des oligomères du peptide amyloïde-beta: implication dans la maladie d'Alzheimer
by: Sarroukh, Rabia
Published: (2011)

Human amyloid-β enriched extracts: evaluation of in vitro and in vivo internalization and molecular characterization
by: Cristina M. Pedrero-Prieto, et al.
Published: (2019-06-01)

Alzheimer’s disease: amyloid-based pathogenesis and potential therapies
by: Yixiu Zhou, et al.
Published: (2018-06-01)

The amyloid-β degradation intermediate Aβ34 is pericyte-associated and reduced in brain capillaries of patients with Alzheimer’s disease
by: Tunahan Kirabali, et al.
Published: (2019-12-01)

CD40L disruption enhances Aβ vaccine-mediated reduction of cerebral amyloidosis while minimizing cerebral amyloid angiopathy and inflammation
by: D. Obregon, et al.
Published: (2008-02-01)

Trafic intracellulaire de l’ARN de la télomérase chez Saccharomyces cerevisiæ : relation entre biogénèse de la télomérase et homéostasie des télomères
by: Gallardo, Franck
Published: (2010)

Trafic intracellulaire de l’ARN de la télomérase chez Saccharomyces cerevisiæ : relation entre biogénèse de la télomérase et homéostasie des télomères
by: Gallardo, Franck
Published: (2010)

The new β amyloid-derived peptide Aβ1–6A2V-TAT(D) prevents Aβ oligomer formation and protects transgenic C. elegans from Aβ toxicity
by: Luisa Diomede, et al.
Published: (2016-04-01)

A mix-and-click method to measure amyloid-β concentration with sub-micromolar sensitivity
by: Christine Xue, et al.
Published: (2017-01-01)

Vaccination against β-Amyloid as a Strategy for the Prevention of Alzheimer’s Disease
by: Francesca Mantile, et al.
Published: (2020-11-01)

SNX8 Enhances Non-amyloidogenic APP Trafficking and Attenuates Aβ Accumulation and Memory Deficits in an AD Mouse
by: Yongzhuang Xie, et al.
Published: (2019-09-01)

Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer’s Disease
by: Kenjiro Ono, et al.
Published: (2020-01-01)

Insulin promotes amyloid precursor protein metabolism in an Alzheimer's disease cell model
by: HU Rong, et al.
Published: (2020-06-01)

Prediction of Cerebral Amyloid Pathology Based on Plasma Amyloid and Tau Related Markers
by: Ting-Bin Chen, et al.
Published: (2021-10-01)

Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?
by: Castillo-Carranza DL, et al.
Published: (2013-12-01)

Oxidative Stress and Beta Amyloid in Alzheimer’s Disease. Which Comes First: The Chicken or the Egg?
by: Elena Tamagno, et al.
Published: (2021-09-01)

High cerebrospinal amyloid-β 42 is associated with normal cognition in individuals with brain amyloidosis
by: Andrea Sturchio, et al.
Published: (2021-08-01)

Removal of blood amyloid-β with hemodialysis reduced brain amyloid-β, confirmed by brain imaging: a case report
by: Kitaguchi N, et al.
Published: (2018-11-01)

Medroxyprogesterone Acetate Impairs Amyloid Beta Degradation in a Matrix Metalloproteinase-9 Dependent Manner
by: Keyana N. Porter, et al.
Published: (2020-04-01)

Results of Beta Secretase-Inhibitor Clinical Trials Support Amyloid Precursor Protein-Independent Generation of Beta Amyloid in Sporadic Alzheimer’s Disease
by: Vladimir Volloch, et al.
Published: (2018-06-01)

Anti-Parallel β-Hairpin Structure in Soluble Aβ Oligomers of Aβ40-Dutch and Aβ40-Iowa
by: Ziao Fu, et al.
Published: (2021-01-01)